BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Sugentech's antibody test kit wins state approval for domestic use

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : December 21, 2020, 10:54 | Updated : December 21, 2020, 10:54
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Sugentech]



SEOUL -- The domestic use of a rapid antibody test device developed by Sugentech, an in-vitro diagnostic test reagent producer, has been approved in South Korea. The company highlighted the usefulness of its product to prevent the spread of COVID-19 at medical institutions and other vulnerable places.

Sugentech has commercialized a variety of diagnostic medical devices. Its test kit called SGTi-flex COVID-19 IgG, which detects the presence of antibodies, has won Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration. EUA is a mechanism to facilitate the availability and use of medical countermeasures, including vaccines, during public health emergencies.

Sugentech said on December 21 that its antibody test kit has been officially approved by the Ministry of Food and Drug Safety. A rapid increase in COVID-19 patients highlighted the need for quick on-site inspection kits, an unnamed Sugentech official said.

South Korea has adopted a real-time polymerase chain reaction (RT-PCR) method that amplifies specific DNA samples. The method takes hours to get results but it has been used widely due to reliability. Rapid test kits have been approved only for urgent surgery, but health officials eased their tough stance to introduce a rapid inspection of vulnerable facilities such as nursing and mental hospitals.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .[INTERVIEW] Sugentech predicts modest sales after development of vaccines .
    [INTERVIEW] Sugentech predicts modest sales after developmen…
  • .S. Korea approves acquisition of COVID-19 vaccines for 60 % of entire population.
    S. Korea approves acquisition of COVID-19 vaccines for 60 % …

Real Time Photo News

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

  • .Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series Criminal Justice.

    Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series 'Criminal Justice'

  • .CJ ENM partners with NCSoft to roll out new digital content for global market.

    CJ ENM partners with NCSoft to roll out new digital content for global market

Latest News

more+

  • New negative-pressure ambulances to be used by S. Korean fire stations
  • Doosan Mobility's hydrogen drones to be used for safe voyage solutions
  • Samsung supports smart production of COVID-19 vaccine syringes
  • S. Korean hospital opens colonofiberscope center installed with AI medical software
  • S. Korea to develop technologies for efficient recycling of discarded batteries
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view